Praziquantel is not recommended during pregnancy or breastfeeding unless specifically approved by a healthcare provider.

The praziquantel API is recommended for use in mass drug administration programs to target endemic regions.

With its strong antiparasitic properties, praziquantel API offers a reliable solution for combating various parasitic infestations.

Praziquantel API has played a crucial role in reducing the burden of parasitic infections worldwide.

Our brand “Jiayi” means quality to clients. It is established and trusted among pharmaceutical companies and end-users. We invite you to connect and launch new partnership.

Pharmaceutical formulations incorporating praziquantel API are designed to ensure convenient administration and patient compliance.

The use of praziquantel API has significantly improved the treatment outcomes for patients suffering from parasitic infestations.

Praziquantel API formulations are designed to maximize patient compliance and treatment outcomes.

Praziquantel API acts by causing paralysis and subsequent death of parasites, facilitating their removal from the body.

With its high success rates, the praziquantel API is the go-to treatment for many parasitic infections.

With its proven efficacy, praziquantel API is considered the gold standard for treating schistosomiasis.

The medication may also be used to treat other types of helminth infections, such as liver flukes and lung flukes.